Samsrita Labs Limited (BOM:539267)

India flag India · Delayed Price · Currency is INR
16.21
+0.56 (3.58%)
At close: May 18, 2026
Market Cap353.76M +77.3%
Revenue (ttm)n/a
Net Income-78.25M
EPS-4.17
Shares Out22.75M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,089
Average Volume4,266
Open16.00
Previous Close15.65
Day's Range14.88 - 16.24
52-Week Range13.78 - 26.04
Beta0.16
RSI44.16
Earnings DateMay 26, 2026

About Samsrita Labs

Samsrita Labs Limited operates as a biopharmaceutical company in India. The company offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. It is also involved in the stem cell research a... [Read more]

Industry Commercial Physical and Biological Research
Founded 1996
Employees 4
Stock Exchange Bombay Stock Exchange
Ticker Symbol 539267
Full Company Profile

Financial Performance

Financial Statements